New Delhi: Hyderabad-based Biological E has got the Drug Controller General of India’s nod to conduct trials of its vaccine Corbevax as booster shots.
India has already rolled out its plan to administer booster doses, which is being called ‘precaution dose’ in the country, from January 10. Bharat Biotech’s Covaxin will be administered as precaution doses to frontline workers and senior citizens with comorbidities.
Corbevax, a two-dose vaccine, is India’s first indigenously developed protein subunit vaccine which has been included in India’s arsenal of vaccines against SARS-CoV-2 on Tuesday after it got the DCGI nod. The vaccine maker company plans to deliver more than 1 billion additional doses globally.
